These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22088743)

  • 1. Re.: A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing.
    Atala A
    J Urol; 2011 May; 185(5):1976. PubMed ID: 22088743
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing.
    Ghosh SK; Kim P; Zhang XA; Yun SH; Moore A; Lippard SJ; Medarova Z
    Cancer Res; 2010 Aug; 70(15):6119-27. PubMed ID: 20610630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel fluorescent probe for the early detection of prostate cancer based on endogenous zinc sensing.
    Fu S; Wan X; Du C; Wang H; Zhou J; Wang Z
    Prostate; 2019 Sep; 79(12):1378-1385. PubMed ID: 31349394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic zinc and prostate specific antigen: an experimental evaluation of their combined diagnostic value.
    Vartsky D; Shilstein S; Bercovich A; Huszar M; Breskin A; Chechik R; Korotinsky S; Malnick SD; Moriel E
    J Urol; 2003 Dec; 170(6 Pt 1):2258-62. PubMed ID: 14634392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Prostatic zinc and prostate specific antigen: an experimental evaluation of their combined diagnostic value.
    Romics I
    J Urol; 2005 Jan; 173(1):324. PubMed ID: 15592107
    [No Abstract]   [Full Text] [Related]  

  • 6. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing novel modalities: field carcinogenesis detection for personalizing prostate cancer management.
    Momi N; Backman V; Brendler CB; Roy HK
    Future Oncol; 2015; 11(20):2737-41. PubMed ID: 26374598
    [No Abstract]   [Full Text] [Related]  

  • 8. Innovative biomarkers for prostate cancer early diagnosis and progression.
    You J; Cozzi P; Walsh B; Willcox M; Kearsley J; Russell P; Li Y
    Crit Rev Oncol Hematol; 2010 Jan; 73(1):10-22. PubMed ID: 19328712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice.
    Katafigioti A; Katafigiotis I; Sfoungaristos S; Alamanis C; Stravodimos K; Anastasiou I; Roumelioti E; Duvdevani M; Constantinides C
    Arch Ital Urol Androl; 2016 Oct; 88(3):195-200. PubMed ID: 27711093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and immunologic diagnosis of cancer. Prostatic cancer.
    Malkin A
    Tumour Biol; 1987; 8(2-3):113-5. PubMed ID: 2452468
    [No Abstract]   [Full Text] [Related]  

  • 11. [The level of evidence for the use of biomarkers in the early detection of prostate cancer].
    Lamy PJ; Gauchez AS; Salomon L; Haugh M; Ceraline J; Fulla Y; Georges A; Larré S; Loric S; Luporsi E; Martin PM; Mazerolles C; Molinié V; Mongiat-Artus P; Piffret J; Thuillier F; Perrin P; Rebillard X;
    Ann Biol Clin (Paris); 2016; 74(2):227-32. PubMed ID: 27029727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Can Be Expected from Prostate Cancer Biomarkers A Clinical Perspective.
    Zapała P; Dybowski B; Poletajew S; Radziszewski P
    Urol Int; 2018; 100(1):1-12. PubMed ID: 28910812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report on Prostate Cancer Tumor Marker Workshop 1999.
    Partin AW; Murphy GP; Brawer MK
    Cancer; 2000 Feb; 88(4):955-63. PubMed ID: 10679666
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate-specific antigen and other serum and urine markers in prostate cancer.
    Stephan C; Ralla B; Jung K
    Biochim Biophys Acta; 2014 Aug; 1846(1):99-112. PubMed ID: 24727384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant prognostic markers for prostate cancer: the search goes on.
    Gelmann EP; Henshall SM
    Ann Intern Med; 2009 May; 150(9):647-9. PubMed ID: 19414846
    [No Abstract]   [Full Text] [Related]  

  • 16. Current biomarkers for diagnosing of prostate cancer.
    Stephan C; Jung K; Ralla B
    Future Oncol; 2015; 11(20):2743-55. PubMed ID: 26358139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker detection technologies and future directions.
    Nimse SB; Sonawane MD; Song KS; Kim T
    Analyst; 2016 Feb; 141(3):740-55. PubMed ID: 26583164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of molecular biology in detection and monitoring of prostate cancer.
    Zummerová A; Böhmer D; Fillo J; Danihel L; Repiská V
    Cesk Patol; 2010 Oct; 46(4):95-7. PubMed ID: 21309265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting prostate cancer behavior--what is a urologist to do?
    Kattan MW
    J Urol; 2008 May; 179(5):1658-9. PubMed ID: 18343424
    [No Abstract]   [Full Text] [Related]  

  • 20. Mn-doped ZnSe d-dots-based α-methylacyl-CoA racemase probe for human prostate cancer cell imaging.
    Gao X; Zhang H; Li Y; Su X
    Anal Bioanal Chem; 2012 Feb; 402(5):1871-7. PubMed ID: 22241581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.